Test Price
2,800 AED✅ Home Collection Available
CAPN3 Gene Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A) Next-Generation Sequencing DNA Test in UAE | 2,800 AED | 2026 DHA Guidelines
فحص جين CAPN3 للحثل العضلي الحزامي الطرفي النمط 2A في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي لعام 2026
Executive Summary – Diagnostic Precision & Patient‑Centric Care
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain, VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: يقدم فحص التسلسل الجيني الكامل لجين CAPN3 تشخيصًا دقيقًا للحثل العضلي الحزامي الطرفي المتنحي الجسدي النمط 2A بدقة 99.9%، مع خدمة سحب منزلي على مستوى المستشفيات وإرشاد طبي لاحق.
Test Overview
The CAPN3 Genetic Test sequences the entire coding region of the calpain‑3 gene, detecting pathogenic variants responsible for limb‑girdle muscular dystrophy autosomal recessive type 2A (LGMD2A), a progressive muscle‑wasting disorder. This definitive genetic diagnosis enables precise prognosis, family planning, and access to emerging gene‑targeted therapies.
يُتيح هذا الاختبار الجيني الكشف الدقيق عن الطفرات المسببة لمرض الحثل العضلي الحزامي الطرفي النمط 2A، مما يدعم التخطيط الأسري وتوجيه العلاج الشخصي.
| Parameter | Our NGS Test | Closest Alternative |
|---|---|---|
| Method | Next‑Generation Sequencing (full CAPN3 gene) | Sanger Sequencing (limited exon coverage) |
| Diagnostic Precision | >99.9% analytical sensitivity | ~95% – may miss deep intronic variants |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price (UAE) | 2,800 AED | 3,200–3,800 AED |
Physician Insight & Safety Protocol
“As a neurologist, I understand the anxiety surrounding a possible muscular dystrophy diagnosis; this test provides definitive genetic clarity, but it must be interpreted alongside electromyography and muscle biopsy findings. A positive result does not define your future—advancements in gene therapy and supportive care have significantly improved quality of life for LGMD2A patients. I strongly recommend pre‑ and post‑test genetic counselling to understand the full implications.”
— Dr. Prabhakar Reddy, DHA License: 61713011
Safety Exclusion Criteria & Red Flags
- Not indicated for: acute febrile illness, recent blood transfusion (within 6 weeks), or when urgent muscle biopsy is required for immediate management.
- Emergency signs: if you experience sudden severe muscle weakness, difficulty breathing, swallowing problems, or chest pain, seek emergency medical care immediately.
- Clinical correlation with a neurologist or clinical geneticist is mandatory; this test alone does not replace a comprehensive neurological evaluation.
Frequently Asked Questions
Q: Who should consider this CAPN3 genetic test?
Q: Comprehensive next‑generation sequencing identifies disease‑causing variants in the calpain‑3 gene, best suited for individuals with progressive proximal muscle weakness, elevated CK levels, or a family history of LGMD. Clinical geneticists and neurologists often recommend it after initial clinical and electromyography findings, or for carrier screening in consanguineous families.
س: ما الفرق بين هذا الاختبار الجيني واختبارات الحثل العضلي الأخرى؟
يُحلل الاختبار الجين CAPN3 كاملاً بتقنية التسلسل الجيني من الجيل التالي مما يكشف الطفرات المتنحية بدقة 99.9%، بينما تعتمد الاختبارات التقليدية على تسلسل سانغر المحدود الذي قد يغفل بعض التغيرات الجينية العميقة.
Q: How do I prepare, and how is home collection arranged?
A simple blood draw or FTA card sample is required; no fasting is needed. Our paid hospital‑grade home collection is available 8 AM – 11 PM with ISO‑certified cold‑chain. Contact WhatsApp +971 54 548 8731 to book your VIP mobile phlebotomy session and verify insurance coverage.
UAE Regulatory & Quality Compliance
- Federal Decree‑Law No. 41 of 2024 (Art. 87) – Licensed health profession practices.
- UAE Child Data Safety (CDS) Law 2026 – strict protections for minors’ genetic data.
- UAE PDPL – full data privacy compliance.
- Facility License: 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Sample Requirements: Whole Blood, Extracted DNA, or One Drop Blood on FTA Card. Pre‑ Genetic Counselling session and clinical history documentation are mandatory.
Top ICD‑10‑CM Codes for 2026: G71.09 (Limb‑girdle muscular dystrophy), Z13.71 (Genetic screening), Z31.430 (Preconception carrier screening).
LOINC: 81644-7 (CAPN3 gene full mutation analysis by Sequencing).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians